| __timestamp | CRISPR Therapeutics AG | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 347523000 |
| Thursday, January 1, 2015 | 12573000 | 479514000 |
| Friday, January 1, 2016 | 42238000 | 581861000 |
| Sunday, January 1, 2017 | 69800000 | 1326361000 |
| Monday, January 1, 2018 | 113773000 | 1197957000 |
| Tuesday, January 1, 2019 | 179362000 | 1154111000 |
| Wednesday, January 1, 2020 | 266946000 | 2215942000 |
| Friday, January 1, 2021 | 438633000 | 1458179000 |
| Saturday, January 1, 2022 | 461645000 | 1585936000 |
| Sunday, January 1, 2023 | 387332000 | 1627594000 |
| Monday, January 1, 2024 | 320653000 | 2606848000 |
Unleashing insights
In the rapidly evolving biotech sector, research and development (R&D) investments are crucial for driving innovation and maintaining competitive advantage. Over the past decade, Incyte Corporation and CRISPR Therapeutics AG have demonstrated contrasting yet significant R&D investment strategies.
From 2014 to 2023, Incyte Corporation consistently increased its R&D spending, peaking in 2020 with a 537% increase from 2014. This steady climb underscores Incyte's commitment to advancing its therapeutic pipeline, particularly in oncology.
CRISPR Therapeutics AG, a pioneer in gene editing, saw its R&D expenses skyrocket by over 25,000% from 2014 to 2023. This surge reflects the company's aggressive pursuit of cutting-edge genetic therapies.
Both companies exemplify the biotech industry's dedication to innovation, albeit through different investment trajectories.
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Analyzing R&D Budgets: Genmab A/S vs Incyte Corporation
Research and Development Expenses Breakdown: Incyte Corporation vs Ascendis Pharma A/S
Incyte Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and Veracyte, Inc.
Incyte Corporation or HUTCHMED (China) Limited: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Viatris Inc. and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and CRISPR Therapeutics AG
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CRISPR Therapeutics AG and Evotec SE